Grip strength assessment offers clinicians three compelling advantages for mortality risk prediction. First, recent evidence demonstrates it outperforms blood pressure—the world’s most routinely measured vital sign—when both are evaluated together as predictors of patient outcomes. Second, handgrip testing reflects whole-body muscle mass and metabolic capacity, serving as a window into systemic health that extends beyond isolated cardiovascular metrics.
Third, the test is remarkably practical: it requires no specialized equipment, takes seconds to perform, and costs minimal resources, making it accessible in any clinical setting regardless of infrastructure limitations. The PURE Study’s findings across 139,691 adults suggest that integrating simple grip strength measurement into preventive care protocols could identify high-risk patients more effectively. Clinically, this implies that muscle strength promotion—through physical activity and resistance training—may represent an underutilized lever for mortality reduction.
Read the full article on GMJ Newsroom.
Was this article helpful?
